======= DYNC1I1 ======= == Gene Information == * **Official Symbol**: DYNC1I1 * **Official Name**: dynein cytoplasmic 1 intermediate chain 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1780|1780]] * **UniProt**: [[https://www.uniprot.org/uniprot/O14576|O14576]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DYNC1I1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DYNC1I1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603772|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. The intermediate chains mediate the binding of dynein to dynactin via its 150 kDa component (p150- glued) DCNT1. May play a role in mediating the interaction of cytoplasmic dynein with membranous organelles and kinetochores. |Dynein IC2| |WD40| |dynein heavy chain binding| |cytoplasmic dynein complex| |dynein light chain binding| |ATP-dependent microtubule motor activity, plus-end-directed| |spectrin binding| |vesicle transport along microtubule| |motor activity| |vesicle cytoskeletal trafficking| |microtubule motor activity| |cytoplasmic ribonucleoprotein granule| |organelle transport along microtubule| |kinetochore| |condensed chromosome kinetochore| |antigen processing and presentation of exogenous peptide antigen via MHC class II| |antigen processing and presentation of peptide or polysaccharide antigen via MHC class II| |antigen processing and presentation of peptide antigen via MHC class II| |recycling endosome| |spindle pole| |vesicle| |transport along microtubule| |establishment of vesicle localization| |cytoskeleton-dependent intracellular transport| |antigen processing and presentation of exogenous peptide antigen| |microtubule-based transport| |antigen processing and presentation of exogenous antigen| |vesicle localization| |antigen processing and presentation of peptide antigen| |endoplasmic reticulum to Golgi vesicle-mediated transport| |antigen processing and presentation| |microtubule binding| |microtubule-based movement| |microtubule| |establishment of organelle localization| |Golgi vesicle transport| |organelle localization| |microtubule-based process| |perinuclear region of cytoplasm| |intracellular transport| |movement of cell or subcellular component| |establishment of localization in cell| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-1.83| |[[:results:exp496|Lead acetate 990μM R08 exp496]]|-1.75| |[[:results:exp307|Rapamycin 2μM plus Cyclosporin-A 3μM R07 exp307]]|1.76| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|1.91| |[[:results:exp390|Pifithrin-alpha 20μM R07 exp390]]|2.12| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15572 * **Expression level (log2 read counts)**: -0.46 {{:chemogenomics:nalm6 dist.png?nolink |}}